Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Sarepta Therapeutics Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
SRPT
Nasdaq
8731
https://www.sarepta.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Sarepta Therapeutics Inc
Sarepta Therapeutics to Announce First Quarter 2024 Financial Results
- Apr 24th, 2024 12:30 pm
10 Unstoppable Stocks That Will Make You Richer
- Apr 14th, 2024 1:39 am
Why Sarepta's First-Quarter Report Is Already Dead In The Water: Analyst
- Apr 8th, 2024 8:13 pm
2 Biotech Stocks to Buy Hand Over Fist in April
- Apr 6th, 2024 12:45 pm
Outperforming ETF manager names a potential ‘50-bagger’ in the stock market
- Apr 2nd, 2024 11:04 am
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Mar 29th, 2024 8:00 pm
Sarepta Therapeutics (SRPT) Up 1.2% Since Last Earnings Report: Can It Continue?
- Mar 29th, 2024 3:30 pm
Sarepta Therapeutics' (NASDAQ:SRPT) growing losses don't faze investors as the stock increases 3.6% this past week
- Mar 29th, 2024 1:12 pm
A Comprehensive Look at Sarepta's Growth and Innovation
- Mar 25th, 2024 2:00 pm
30 Biggest Biotechnology Companies in the World
- Mar 17th, 2024 12:50 pm
Billionaire Ken Fisher and Corporate Insiders Are Buying These 10 Stocks
- Mar 14th, 2024 7:53 pm
Does This 1 New Threat Make Sarepta Therapeutics Stock Worth Selling?
- Mar 13th, 2024 12:00 pm
Director Wigzell Hans Lennart Rudolf Sells 15,000 Shares of Sarepta Therapeutics Inc (SRPT)
- Mar 12th, 2024 5:18 am
Billionaire Ray Dalio and Insiders Love These 10 Stocks
- Mar 11th, 2024 1:03 pm
Director Stephen Mayo Sells 3,135 Shares of Sarepta Therapeutics Inc (SRPT)
- Mar 7th, 2024 4:54 am
Sarepta Therapeutics Stock Has 73% Upside, According to 1 Wall Street Analyst
- Mar 4th, 2024 2:47 pm
Sarepta Therapeutics to Present at Upcoming Investor Conferences
- Mar 4th, 2024 1:30 pm
Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Consensus Forecasts Have Become A Little Darker Since Its Latest Report
- Mar 2nd, 2024 12:17 pm
Decoding Sarepta Therapeutics Inc (SRPT): A Strategic SWOT Insight
- Mar 2nd, 2024 5:05 am
Sarepta Therapeutics Full Year 2023 Earnings: EPS Beats Expectations
- Mar 1st, 2024 10:17 am
Scroll